RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Procter & Gamble Health Stock

Procter & Gamble Health Stocks 2025

Procter & Gamble Health Stocks

16.6 M

Ticker

PGHL.NS

ISIN

INE199A01012

In 2025, Procter & Gamble Health had 16.6 M outstanding stocks, a 0% change from the 16.6 M stocks in the previous year.

The Procter & Gamble Health Stocks history

YEARNUMBER OF STOCKS (undefined INR)
2026e16.6
2025e16.6
202416.6
202316.6
202217
202117
202017
201916.6
201817
201717
201617
201517
201417
201317
201217
201117
201017
200917
200817
200717
200617
200517

Procter & Gamble Health shares outstanding

The number of shares was Procter & Gamble Health in 2024 — This indicates how many shares 16.599 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Procter & Gamble Health earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Procter & Gamble Health's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Procter & Gamble Health’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Procter & Gamble Health's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Procter & Gamble Health Aktienanalyse

What does Procter & Gamble Health do?

Procter & Gamble Health Ltd. is a leading company in the health and hygiene products industry. The company was founded in 1837 by William Procter and James Gamble in Cincinnati, Ohio. Since then, the company has undergone incredible development and is now a global corporation with more than 95,000 employees and an annual revenue of nearly $70 billion. The business model of Procter & Gamble Health Ltd. is focused on providing customers with high-quality products at an affordable price. The company operates in various areas, including household products, health products, beauty products, and hygiene products. The different divisions of Procter & Gamble Health Ltd. include the following areas: Household products: Brands like Ariel, Ace, and Lenor are among the most well-known offerings from Procter & Gamble Health. The company is also active in the textile care category and offers various products such as the brand Downy. Health products: The company's health products focus on oral and dental care, as well as pain relief and digestive aids. Brands like Oral-B and Vick are among the most well-known in the portfolio. Beauty products: Procter & Gamble Health offers a wide range of beauty products such as shampoo, conditioner, and hair dye. Herbal Essences, Pantene, and Wella are among the most well-known brands in this area. Hygiene products: The company offers products such as toilet paper, diapers, and cleaning agents. Pampers, Charmin, and Swiffer are among the most well-known brands. Procter & Gamble Health Ltd. has a very extensive product portfolio, which also includes brands like Always, Old Spice, and Gillette. Procter & Gamble Health is an innovative company that continuously offers its customers new and improved products. An example of this is the development of Tide Pods, a novel way to wash laundry that is packaged in a completely soluble shell. In addition to continuous product development, the company also places great importance on sustainability and social responsibility. Procter & Gamble Health actively engages in environmental protection and advocates for the improvement of working conditions and quality of life for people worldwide. In summary, Procter & Gamble Health Ltd. is a successful company that enjoys an excellent reputation due to its innovative strength, extensive product range, and commitment to sustainability and social responsibility. Procter & Gamble Health ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Procter & Gamble Health's Shares Outstanding

Procter & Gamble Health's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Procter & Gamble Health’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Procter & Gamble Health’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Procter & Gamble Health’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Procter & Gamble Health stock

How many stocks are there of Procter & Gamble Health?

The current number of stocks of Procter & Gamble Health is 16.6 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Procter & Gamble Health are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Procter & Gamble Health evolved in recent years?

The number of shares of Procter & Gamble Health has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Procter & Gamble Health as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Procter & Gamble Health?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Procter & Gamble Health pay?

Over the past 12 months, Procter & Gamble Health paid a dividend of 270 INR . This corresponds to a dividend yield of about 5.29 %. For the coming 12 months, Procter & Gamble Health is expected to pay a dividend of 306.55 INR.

What is the dividend yield of Procter & Gamble Health?

The current dividend yield of Procter & Gamble Health is 5.29 %.

When does Procter & Gamble Health pay dividends?

Procter & Gamble Health pays a quarterly dividend. This is distributed in the months of December, March, December, March.

How secure is the dividend of Procter & Gamble Health?

Procter & Gamble Health paid dividends every year for the past 14 years.

What is the dividend of Procter & Gamble Health?

For the upcoming 12 months, dividends amounting to 306.55 INR are expected. This corresponds to a dividend yield of 6.01 %.

In which sector is Procter & Gamble Health located?

Procter & Gamble Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von Procter & Gamble Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Procter & Gamble Health from 3/7/2025 amounting to 80 INR, you needed to have the stock in your portfolio before the ex-date on 2/21/2025.

When did Procter & Gamble Health pay the last dividend?

The last dividend was paid out on 3/7/2025.

What was the dividend of Procter & Gamble Health in the year 2024?

In the year 2024, Procter & Gamble Health distributed 145 INR as dividends.

In which currency does Procter & Gamble Health pay out the dividend?

The dividends of Procter & Gamble Health are distributed in INR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Procter & Gamble Health

Our stock analysis for Procter & Gamble Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Procter & Gamble Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.